Kapil Dhingra's Insider Trades & SAST Disclosures
Kapil Dhingra's most recent trade in Replimune Group Inc was a trade of 32,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on April 1, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Kapil Dhingra.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Replimune Group Inc | Kapil Dhingra | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 32,000 | 32,000 | - | - | Stock Option (right to buy) | |
| LAVA Therapeutics NV | Kapil Dhingra | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 33,390 | 33,390 | - | - | Common Shares (Right to Buy) | |
| Black Diamond Therapeutics... | Kapil Dhingra | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 30,550 | 30,550 | - | - | Stock Option (Right to Buy) | |
| CARGO Therapeutics Inc | Kapil Dhingra | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 11,871 | 11,871 | - | - | Stock Option (Right to Buy) | |
| CARGO Therapeutics Inc | Kapil Dhingra | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2024 | 49,265 | 49,265 | - | - | Stock Option (Right to Buy) | |
| Replimune Group Inc | Kapil Dhingra | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 32,000 | 32,000 | - | - | Stock Option (right to buy) | |
| Black Diamond Therapeutics... | Kapil Dhingra | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2023 | 16,500 | 16,500 | - | - | Stock Option (Right to Buy) | |
| Replimune Group Inc | Kapil Dhingra | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2023 | 25,200 | 25,200 | - | - | Stock Option (right to buy) | |
| Black Diamond Therapeutics... | Kapil Dhingra | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Replimune Group Inc | Kapil Dhingra | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 16,500 | 16,500 | - | - | Stock Option (right to buy) | |
| Black Diamond Therapeutics... | Kapil Dhingra | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Replimune Group Inc | Kapil Dhingra | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 16,500 | 16,500 | - | - | Stock Option (right to buy) | |
| Black Diamond Therapeutics... | Kapil Dhingra | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2021 | 29,842 | 29,842 | - | - | Stock Option (Right to Buy) | |
| Replimune Group Inc | Kapil Dhingra | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2020 | 40,000 | 3,169 | - | - | Stock Option (right to buy) | |
| Replimune Group Inc | Kapil Dhingra | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.75 per share. | 07 Dec 2020 | 40,000 | 40,000 (0%) | 0% | 1.8 | 70,000 | Common Stock |
| Replimune Group Inc | Kapil Dhingra | Director | Sale of securities on an exchange or to another person at price $ 45.09 per share. | 07 Dec 2020 | 24,675 | 15,325 (0%) | 0% | 45.1 | 1,112,596 | Common Stock |
| Replimune Group Inc | Kapil Dhingra | Director | Sale of securities on an exchange or to another person at price $ 46.22 per share. | 07 Dec 2020 | 13,523 | 1,802 (0%) | 0% | 46.2 | 625,033 | Common Stock |
| Replimune Group Inc | Kapil Dhingra | Director | Sale of securities on an exchange or to another person at price $ 47.04 per share. | 07 Dec 2020 | 1,802 | 0 (0%) | 0% | 47.0 | 84,766 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges